Shukla Sath
Insider CIK 1782817 · ZIOP EVP, Chief Financial Officer · SPRO Chief Financial Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRO Spero Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-05 | 6,139 | $0.78 | $4.8K | 1,886,077 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-05 | 42,786 | $0.78 | $33.4K | 1,843,291 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-05 | 106,408 | $0.78 | $83.0K | 1,736,883 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2025-02-03 | 2025-02-05 | 751,407 | — | $0 | 1,892,216 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2024-08-27 | 2024-08-29 | 2,757 | $1.35 | $3.7K | 1,140,809 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2024-08-05 | 2024-08-06 | 17,641 | $1.31 | $23.1K | 1,143,566 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2024-08-02 | 2024-08-06 | 14,800 | $1.32 | $19.5K | 1,161,207 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2024-02-05 | 2024-02-05 | 45,093 | $1.45 | $65.4K | 1,176,007 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2024-02-02 | 2024-02-05 | 30,901 | $1.37 | $42.3K | 1,221,100 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2024-02-01 | 2024-02-05 | 679,501 | — | $0 | 1,252,001 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2023-08-29 | 2023-08-30 | 4,163 | $1.30 | $5.4K | 572,500 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2023-08-28 | 2023-08-30 | 1,854 | $1.26 | $2.3K | 576,663 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2023-08-01 | 2023-08-03 | 266,000 | — | $0 | 578,517 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2023-02-02 | 2023-02-03 | 9,504 | $1.83 | $17.4K | 312,517 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2023-02-01 | 2023-02-03 | 265,957 | — | $0 | 322,021 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2022-08-29 | 2022-08-30 | 6,017 | $0.89 | $5.4K | 56,064 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 53,190 | — | $0 | 53,190 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2022-02-01 | 2022-02-03 | 38,014 | — | $0 | 62,081 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2021-08-26 | 2021-08-30 | 24,067 | — | $0 | 24,067 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2020-01-29 | 2020-01-31 | 123,900 | — | $0 | 123,900 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award | 2020-01-29 | 2020-01-31 | 80,500 | — | $0 | 80,500 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2019-07-22 | 2019-07-24 | 400,000 | — | $0 | 400,000 | SEC↗ |